These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20101834)

  • 1. [Implantable defibrillator--with focus on primary prevention. Detailed patient information about risks and benefits is required].
    Jensen SM; Kesek M
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3236, 3238-41. PubMed ID: 20101834
    [No Abstract]   [Full Text] [Related]  

  • 2. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 5. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary prophylactic treatment with implantable defibrillator in high risk patients].
    Møller M; Haghfelt T
    Ugeskr Laeger; 2000 Jul; 162(31):4160-1. PubMed ID: 10962922
    [No Abstract]   [Full Text] [Related]  

  • 7. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 9. Do traditional VT zones improve outcome in primary prevention ICD patients?
    Duncan E; Thomas G; Johns N; Pfeffer C; Appanna G; Shah N; Hunter R; Finlay M; Schilling RJ; Sporton S
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1353-8. PubMed ID: 20727095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 11. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
    Steinberg JS; Martins J; Sadanandan S; Goldner B; Menchavez E; Domanski M; Russo A; Tullo N; Hallstrom A;
    Am Heart J; 2001 Sep; 142(3):520-9. PubMed ID: 11526368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
    Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
    Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning more about indications for implantable cardioverter-defibrillators.
    Myerburg RJ; Castellanos A
    J Am Coll Cardiol; 1999 Oct; 34(4):1096-8. PubMed ID: 10520796
    [No Abstract]   [Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.